NLRP3 inflammasome-driven IL-1β and IL-18 contribute to lipopolysaccharide-induced septic cardiomyopathy

2023/05/10 by Kenta Fujimura, Tadayoshi Karasawa, Takanori Komada +9 · 25 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammasome and immune disorders #Sepsis Diagnosis and Treatment #Autoimmune and Inflammatory Disorders Research

paper · doi:10.1016/j.yjmcc.2023.05.003

Cited by

• The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. [europepmc]
• The link between neutrophils, NETs, and NLRP3 inflammasomes: The dual effect of CD177 and its therapeutic potential in acute respiratory distress syndrome/acute lung injury. [europepmc]
• Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy. [europepmc]
• Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity. [europepmc]
• Connecting the Dots: Exploring the Interplay Between Preeclampsia and Peripartum Cardiomyopathy. [europepmc]
• NLRP3-mediated autophagy dysfunction links gut microbiota dysbiosis to tau pathology in chronic sleep deprivation. [europepmc]
• Role of gasdermin D in inflammatory diseases: from mechanism to therapeutics. [europepmc]
• Expression of NLRP3 in serum and induced sputum of children with asthma and their relationship with disease severity. [europepmc]
• Study on the mechanism of Shenmai injection in the treatment of sepsis. [europepmc]
• A murine model of acute and prolonged abdominal sepsis, supported by intensive care, reveals time-dependent metabolic alterations in the heart. [europepmc]
• NLRP3 Inflammasome Targeting Offers a Novel Therapeutic Paradigm for Sepsis-Induced Myocardial Injury. [europepmc]
• Exploring the pathogenesis of sepsis-induced cardiomyopathy: Multilayered mechanisms and clinical responses. [europepmc]
• Immunomodulatory and cardio-protective effects of differentially originated multipotent mesenchymal stroma cells during polymicrobial sepsis in mice. [europepmc]
• Pyroptosis in sepsis-associated acute kidney injury: mechanisms and therapeutic perspectives. [europepmc]
• Pathogenesis and treatment strategies of sepsis-induced myocardial injury: modern and traditional medical perspectives. [europepmc]
• IL-33-primed NLRP3 inflammasome in basophils drives IL-1β production and initiates atopic dermatitis inflammation. [europepmc]
• Cardiomyocyte mitochondrial mono-ADP-ribosylation dictates cardiac tolerance to sepsis by configuring bioenergetic reserve in male mice. [europepmc]
• Shenling Baizhu San attenuates testicular spermatogenic dysfunction in hyperuricemic mice via dual modulation of MAPK/NF-κB and NLRP3 inflammasome pathways. [europepmc]
• Amphiregulin attenuates sepsis-induced myocardial dysfunction by maintaining the localization of connexin43. [europepmc]
• The inflammatory clock: how cGAS-STING ticks in the aging ovary. [europepmc]
• Sepsis-induced cardiomyopathy: mechanisms, epidemiology, diagnosis, and treatments. [europepmc]
• Circulating and Respiratory Biomarkers in Sepsis-Induced ARDS: Diagnostic and Prognostic Insights - A Narrative Review. [europepmc]
• The non-scaffold effects of natural polysaccharides in promoting organ regeneration: a review. [europepmc]
• Pathophysiology-guided biomarkers and therapeutics for precision trauma medicine in polytrauma with musculoskeletal injuries. [europepmc]
• Bat-Inspired Longevity: Immune Damage Management and Nutritional Modulation for Healthy Aging. [europepmc]